Literature DB >> 20609352

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

Haihe Wang1, Leah A Vardy, Cheng Peow Tan, Jia Min Loo, Ke Guo, Jie Li, Seng Gee Lim, Jianbiao Zhou, Wee Joo Chng, Siok Bian Ng, Hui Xiang Li, Qi Zeng.   

Abstract

Overexpression of phosphatase of regenerating liver (PRL)-3 is associated with the progression of diverse human cancers. We show that the overexpression of PRL-3 protein is not directly associated with its transcript levels, indicating the existence of an underlying posttranscriptional regulation. The 5' untranslanted region (UTR) of PRL-3 mRNA possesses triple GCCCAG motifs capable of suppressing mRNA translation through interaction with PolyC-RNA-binding protein 1 (PCBP1), which retards PRL-3 mRNA transcript incorporation into polyribosomes. Overexpression of PCBP1 inhibits PRL-3 expression and inactivates AKT, whereas knockdown of PCBP1 causes upregulation of PRL-3 protein levels, activation of AKT, and promotion of tumorigenesis. An inverse correlation between protein levels of PRL-3 and PCBP1 in human primary cancers supports the clinical relevance. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20609352     DOI: 10.1016/j.ccr.2010.04.028

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  89 in total

1.  DNA polymerase η is regulated by poly(rC)-binding protein 1 via mRNA stability.

Authors:  Cong Ren; Seong-Jun Cho; Yong-Sam Jung; Xinbin Chen
Journal:  Biochem J       Date:  2014-12-15       Impact factor: 3.857

2.  Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.

Authors:  Serge Hardy; Elie Kostantin; Shan Jin Wang; Tzvetena Hristova; Gabriela Galicia-Vázquez; Pavel V Baranov; Jerry Pelletier; Michel L Tremblay
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

3.  Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.

Authors:  Yosuke Funato; Daisuke Yamazaki; Shin Mizukami; Lisa Du; Kazuya Kikuchi; Hiroaki Miki
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

4.  Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.

Authors:  Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

Review 5.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

Review 6.  TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Authors:  Breege V Howley; Philip H Howe
Journal:  Cytokine       Date:  2018-02-01       Impact factor: 3.861

7.  PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

Authors:  Min Thura; Abdul Qader Omer Al-Aidaroos; Wei Peng Yong; Koji Kono; Abhishek Gupta; You Bin Lin; Kousaku Mimura; Jean Paul Thiery; Boon Cher Goh; Patrick Tan; Ross Soo; Cheng William Hong; Lingzhi Wang; Suling Joyce Lin; Elya Chen; Sun Young Rha; Hyun Cheol Chung; Jie Li; Sayantani Nandi; Hiu Fung Yuen; Shu-Dong Zhang; Yeoh Khay Guan; Jimmy So; Qi Zeng
Journal:  JCI Insight       Date:  2016-06-16

8.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

9.  Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma.

Authors:  Shan Xia; Zigang Zhao; Fang Xie; Jing He; Hengjin Li
Journal:  Tumour Biol       Date:  2016-09-15

Review 10.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.